ICT BIO 2008 - Combining the Power of ICT with Biomedical Sciences

Major diseases like cancer, neurological and cardiovascular diseases are complex in nature involving environmental, life style, ageing and genetic components. One of the future challenges is to integrate the knowledge of all these different components into robust and fully reliable computer models and "in silico" environments that will help the development and testing of new therapies for better prediction and prevention tools in healthcare.

An integrative research approach is therefore required to better understand the complex mechanisms behind human diseases. In this approach, all processes that occur at multiple levels from molecules to cells, organs and organisms are seen not as separate events but as parts of a multi-scale system which aims at improving the understanding of the human health and diseases.

To face this challenge a new generation of multidisciplinary science fields is emerging at the crossroads of Information Technology, Medicine and Biology that provide "in silico" multi-scale modeling and simulation in medicine and biology. For example, patient-specific computer models of human cells or organs can bring new understanding of disease, support discovery of new drugs or can help visualising the effects of different choices of treatments.

To realise this ambitious vision at the crossroads of Information and Communication Technologies and Biomedical Sciences, researchers from different disciplines must work together on virtually everything that can be observed and measured at multiple biological levels in relation to human physiological diseases. The European Commission is investing in this topic through complementary research programmes in Information and Communication Technologies and Health research.

The Directorate-General Information Society and Media (DG INFSO) supports this integrative research through funding of projects in the area of multi-scale modeling and simulation known as the "Virtual Physiological Human" (VPH) initiative. The Directorate-General Research (DG RTD) supports through funding of projects in the areas of health research and systems biology.

The conference will take place over two days (Oct. 23-24). Each day will start with a plenary session featuring high-level policy speakers including EU Commissioners, Member of Parliaments, prominent scientists and international funding agency representatives from the EU, US and beyond.

In the afternoon, parallel sessions will focus on themes incorporating ICT and life sciences such as multi-scale modeling in cancer research, heart and cardiovascular diseases, muscular-skeleton systems, and ageing. The conference website is updated regularly with the latest information on the sessions and exhibition.

Media events (press-conference, press release, demos to media) will communicate to non-specialists the importance of the synergy between ICT, Biomedical Sciences and Health research and the concrete benefits for all citizens in terms of better healthcare.

During both days an exhibition will be held at the conference venue showcasing amongst others 3D medical imaging and prototypes, interactive audiovisual and technical demonstrations. These demos will be exhibited by on-going research projects showing concrete results in this multidisciplinary research field. The exhibition will be a great opportunity for the public to see the applications of the latest technologies and new tools that will help the development of novel therapies for a more predictive and preventive healthcare.

The Conference is free of charge and online registration is compulsory, entrance will not be permitted without the confirmation letter.

Please note that as the number of seats in the meeting rooms is limited, the Commission reserves the right to confirm, on a free selection basis, only as many registrations as seats available. The confirmation of attendance letter will be sent at the latest on 15th September.

Have Your Say
Logged-in site visitors are able to use the site's 'Comment' function to show their interest in or comment on the event in one of two ways:

  • suggest a contribution - your idea will be forwarded to the session coordinator. If successful, you will be able to develop it further by adding documents;
  • comment on a session - relevant questions and comments will be communicated to the chairman of the session and potentially addressed during the session.

Alongside the conference, the 1st Transatlantic Workshop on Multiscale Cancer Modelling will take place at the same venue.

Computational and mathematical cancer modelling is already a driving force behind interdisciplinary cancer systems biology. Understanding cancer as a complex dynamic bio system requires finding ways to investigate and ultimately target its many constituents and their dynamic relationships across multiple scales in space and time - i.e., multi-scale modelling and simulation. Geared towards translation into clinical practice, long term goals of these modelling approaches include supporting patient specific treatment optimization.

In recognizing the significant contribution of teams on both sides of the Atlantic to this emergent field of in silico oncology, the US National Cancer Institute and the European Commission jointly support a workshop that is being co-organized by NCI’s Center for the Development of a Virtual Tumor, CViT, and EC's Advancing Clinico Genomics Trials Program, ACGT.

This workshop aims to present cutting edge approaches, to demonstrate the field's potential and to discuss common challenges it faces in moving forward. The ideal outcome is facilitated interaction between the teams, increased visibility of the achievements beyond the nascent community and formulation of a shared vision that can be advanced into joint funding programs.

The following modelling and simulation topics will be addressed: carcinogenesis, prevascular and vascular progression, invasion and metastasis, tumour growth across spatiotemporal scales and clinically oriented tumour modelling. All major multilevel approaches i.e. bottom-up, top-down and middle-out will be delineated through carefully selected paradigms. Initiatives regarding translation of multiscale cancer models into the arena of clinical trials will be outlined and their potential will be discussed.

Programme is available at the ICT BIO conference website under the Transatlantic Workshop button.

For further information and registration, please visit:
http://ec.europa.eu/information_society/
events/ict_bio/2008/index_en.htm

Related news articles:

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...